APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cytotoxicity Testing Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cytotoxicity Testing Services Market Outlook and Growth Opportunities 2026

12 August 2026202 pages

Choose your research edition.

Industry ResearchCytotoxicity Testing Services Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cytotoxicity Testing Services Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Cytotoxicity Testing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cytotoxicity Testing Services Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Cytotoxicity Testing Services Market Analysis and Forecast 2026-2032189 pages · $4,950 USD

Market perspective

The global Cytotoxicity Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cytotoxicity Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cytotoxicity Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cytotoxicity Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cytotoxicity Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cytotoxicity Testing Services market include Sartorius, Eurofins Scientific, TÜV SÜD, Nelson Labs, Pacific BioLabs, Emery Pharma, UFAG Laboratorien AG, NorthEast BioLab and Biosafe Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cytotoxicity Testing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cytotoxicity Testing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cytotoxicity Testing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cytotoxicity Testing Services market.

Cytotoxicity Testing Services Segment by Company

Sartorius

Eurofins Scientific

TÜV SÜD

Nelson Labs

Pacific BioLabs

Emery Pharma

UFAG Laboratorien AG

NorthEast BioLab

Biosafe Ltd

Creative Bioarray

Evercyte

IONTOX

Applied StemCell

Xenometrix AG

Medicilon

UL

SGS

iuvo BioScience

Cytotoxicity Testing Services Segment by Type

Elution Testing Method

Agar Overlay Method

Direct Contact Method

MTT Assay Method

Others

Cytotoxicity Testing Services Segment by Application

Drug

Medical Instruments

Cosmetics and Personal Care

Others

Cytotoxicity Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cytotoxicity Testing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cytotoxicity Testing Services key companies, revenue, market share, and recent developments.

3. To split the Cytotoxicity Testing Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cytotoxicity Testing Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cytotoxicity Testing Services significant trends, drivers, influence factors in global and regions.

6. To analyze Cytotoxicity Testing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cytotoxicity Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cytotoxicity Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cytotoxicity Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cytotoxicity Testing Services industry.

Chapter 3: Detailed analysis of Cytotoxicity Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cytotoxicity Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cytotoxicity Testing Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cytotoxicity Testing Services Industry Trends Table 2. Cytotoxicity Testing Services Industry Drivers Table 3. Cytotoxicity Testing Services Industry Opportunities and Challenges Table 4. Cytotoxicity Testing Services Industry Restraints Table 5. Global Cytotoxicity Testing Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cytotoxicity Testing Services Revenue Share by Company (2021-2026) Table 7. Global Cytotoxicity Testing Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cytotoxicity Testing Services Key Company Manufacturing Base & Headquarters Table 9. Global Cytotoxicity Testing Services Company, Product Type & Application Table 10. Global Cytotoxicity Testing Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cytotoxicity Testing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Elution Testing Method Table 15. Significant Companies of Agar Overlay Method Table 16. Significant Companies of Direct Contact Method Table 17. Significant Companies of MTT Assay Method Table 18. Significant Companies of Others Table 19. Global Cytotoxicity Testing Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Cytotoxicity Testing Services Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Cytotoxicity Testing Services Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Cytotoxicity Testing Services Sales Value Share by Type (2021-2026) Table 23. Global Cytotoxicity Testing Services Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Drug Table 25. Significant Companies of Medical Instruments Table 26. Significant Companies of Cosmetics and Personal Care Table 27. Significant Companies of Others Table 28. Global Cytotoxicity Testing Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Cytotoxicity Testing Services Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Cytotoxicity Testing Services Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Cytotoxicity Testing Services Sales Value Share by Application (2021-2026) Table 32. Global Cytotoxicity Testing Services Sales Value Share by Application (2027-2032) Table 33. Global Cytotoxicity Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cytotoxicity Testing Services Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Cytotoxicity Testing Services Sales Value Share by Region (2021-2026) Table 36. Global Cytotoxicity Testing Services Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Cytotoxicity Testing Services Sales Value Share by Region (2027-2032) Table 38. Global Cytotoxicity Testing Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Cytotoxicity Testing Services Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Cytotoxicity Testing Services Sales Value Market Share by Country (2021-2026) Table 41. Global Cytotoxicity Testing Services Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Cytotoxicity Testing Services Sales Value Market Share by Country (2027-2032) Table 43. Sartorius Company Information Table 44. Sartorius Business Overview Table 45. Sartorius Cytotoxicity Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Sartorius Cytotoxicity Testing Services Product Portfolio Table 47. Sartorius Recent Development Table 48. Eurofins Scientific Company Information Table 49. Eurofins Scientific Business Overview Table 50. Eurofins Scientific Cytotoxicity Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Eurofins Scientific Cytotoxicity Testing Services Product Portfolio Table 52. Eurofins Scientific Recent Development Table 53. TÜV SÜD Company Information Table 54. TÜV SÜD Business Overview Table 55. TÜV SÜD Cytotoxicity Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. TÜV SÜD Cytotoxicity Testing Services Product Portfolio Table 57. TÜV SÜD Recent Development Table 58. Nelson Labs Company Information Table 59. Nelson Labs Business Overview Table 60. Nelson Labs Cytotoxicity Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Nelson Labs Cytotoxicity Testing Services Product Portfolio Table 62. Nelson Labs Recent Development Table 63. Pacific BioLabs Company Information Table 64. Pacific BioLabs Business Overview Table 65. Pacific BioLabs Cytotoxicity Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Pacific BioLabs Cytotoxicity Testing Services Product Portfolio Table 67. Pacific BioLabs Recent Development Table 68. Emery Pharma Company Information Table 69. Emery Pharma Business Overview Table 70. Emery Pharma Cytotoxicity Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Emery Pharma Cytotoxicity Testing Services Product Portfolio Table 72. Emery Pharma Recent Development Table 73. UFAG Laboratorien AG Company Information Table 74. UFAG Laboratorien AG Business Overview Table 75. UFAG Laboratorien AG Cytotoxicity Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. UFAG Laboratorien AG Cytotoxicity Testing Services Product Portfolio Table 77. UFAG Laboratorien AG Recent Development Table 78. NorthEast BioLab Company Information Table 79. NorthEast BioLab Business Overview Table 80. NorthEast BioLab Cytotoxicity Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. NorthEast BioLab Cytotoxicity Testing Services Product Portfolio Table 82. NorthEast BioLab Recent Development Table 83. Biosafe Ltd Company Information Table 84. Biosafe Ltd Business Overview Table 85. Biosafe Ltd Cytotoxicity Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Biosafe Ltd Cytotoxicity Testing Services Product Portfolio Table 87. Biosafe Ltd Recent Development Table 88. Creative Bioarray Company Information Table 89. Creative Bioarray Business Overview Table 90. Creative Bioarray Cytotoxicity Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Creative Bioarray Cytotoxicity Testing Services Product Portfolio Table 92. Creative Bioarray Recent Development Table 93. Evercyte Company Information Table 94. Evercyte Business Overview Table 95. Evercyte Cytotoxicity Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Evercyte Cytotoxicity Testing Services Product Portfolio Table 97. Evercyte Recent Development Table 98. IONTOX Company Information Table 99. IONTOX Business Overview Table 100. IONTOX Cytotoxicity Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. IONTOX Cytotoxicity Testing Services Product Portfolio Table 102. IONTOX Recent Development Table 103. Applied StemCell Company Information Table 104. Applied StemCell Business Overview Table 105. Applied StemCell Cytotoxicity Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Applied StemCell Cytotoxicity Testing Services Product Portfolio Table 107. Applied StemCell Recent Development Table 108. Xenometrix AG Company Information Table 109. Xenometrix AG Business Overview Table 110. Xenometrix AG Cytotoxicity Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Xenometrix AG Cytotoxicity Testing Services Product Portfolio Table 112. Xenometrix AG Recent Development Table 113. Medicilon Company Information Table 114. Medicilon Business Overview Table 115. Medicilon Cytotoxicity Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Medicilon Cytotoxicity Testing Services Product Portfolio Table 117. Medicilon Recent Development Table 118. UL Company Information Table 119. UL Business Overview Table 120. UL Cytotoxicity Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. UL Cytotoxicity Testing Services Product Portfolio Table 122. UL Recent Development Table 123. SGS Company Information Table 124. SGS Business Overview Table 125. SGS Cytotoxicity Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. SGS Cytotoxicity Testing Services Product Portfolio Table 127. SGS Recent Development Table 128. iuvo BioScience Company Information Table 129. iuvo BioScience Business Overview Table 130. iuvo BioScience Cytotoxicity Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. iuvo BioScience Cytotoxicity Testing Services Product Portfolio Table 132. iuvo BioScience Recent Development Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Cytotoxicity Testing Services Product Image Figure 2. Global Cytotoxicity Testing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cytotoxicity Testing Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Cytotoxicity Testing Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Elution Testing Method Image Figure 8. Agar Overlay Method Image Figure 9. Direct Contact Method Image Figure 10. MTT Assay Method Image Figure 11. Others Image Figure 12. Global Cytotoxicity Testing Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Cytotoxicity Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Cytotoxicity Testing Services Sales Value Share by Type (2021-2032) Figure 15. Drug Image Figure 16. Medical Instruments Image Figure 17. Cosmetics and Personal Care Image Figure 18. Others Image Figure 19. Global Cytotoxicity Testing Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cytotoxicity Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Cytotoxicity Testing Services Sales Value Share by Application (2021-2032) Figure 22. Global Cytotoxicity Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Cytotoxicity Testing Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Cytotoxicity Testing Services Sales Value (2021-2032) & (US$ Million) Figure 25. North America Cytotoxicity Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Cytotoxicity Testing Services Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Cytotoxicity Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Cytotoxicity Testing Services Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Cytotoxicity Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Cytotoxicity Testing Services Sales Value (2021-2032) & (US$ Million) Figure 31. South America Cytotoxicity Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Cytotoxicity Testing Services Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Cytotoxicity Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Elution Testing Method
  • Agar Overlay Method
  • Direct Contact Method
  • MTT Assay Method
  • Others
Applications
  • Drug
  • Medical Instruments
  • Cosmetics and Personal Care
  • Others
Companies covered
  • Sartorius
  • Eurofins Scientific
  • TÜV SÜD
  • Nelson Labs
  • Pacific BioLabs
  • Emery Pharma
  • UFAG Laboratorien AG
  • NorthEast BioLab
  • Biosafe Ltd
  • Creative Bioarray
  • Evercyte
  • IONTOX
  • Applied StemCell
  • Xenometrix AG
  • Medicilon
  • UL
  • SGS
  • iuvo BioScience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cytotoxicity Testing Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cytotoxicity Testing Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cytotoxicity Testing Services Market Dynamics
  1. 2.1 Cytotoxicity Testing Services Industry Trends
  2. 2.2 Cytotoxicity Testing Services Industry Drivers
  3. 2.3 Cytotoxicity Testing Services Industry Opportunities and Challenges
  4. 2.4 Cytotoxicity Testing Services Industry Restraints
3 Cytotoxicity Testing Services Market by Company
  1. 3.1 Global Cytotoxicity Testing Services Company Revenue Ranking in 2025
  2. 3.2 Global Cytotoxicity Testing Services Revenue by Company (2021-2026)
  3. 3.3 Global Cytotoxicity Testing Services Company Ranking (2024-2026)
  4. 3.4 Global Cytotoxicity Testing Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Cytotoxicity Testing Services Company Product Type and Application
  6. 3.6 Global Cytotoxicity Testing Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cytotoxicity Testing Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cytotoxicity Testing Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cytotoxicity Testing Services Market by Type
  1. 4.1 Cytotoxicity Testing Services Type Introduction
  2. 4.1.1 Elution Testing Method
  3. 4.1.2 Agar Overlay Method
  4. 4.1.3 Direct Contact Method
  5. 4.1.4 MTT Assay Method
  6. 4.1.5 Others
  7. 4.2 Global Cytotoxicity Testing Services Sales Value by Type
  8. 4.2.1 Global Cytotoxicity Testing Services Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Cytotoxicity Testing Services Sales Value by Type (2021-2032)
  10. 4.2.3 Global Cytotoxicity Testing Services Sales Value Share by Type (2021-2032)
5 Cytotoxicity Testing Services Market by Application
  1. 5.1 Cytotoxicity Testing Services Application Introduction
  2. 5.1.1 Drug
  3. 5.1.2 Medical Instruments
  4. 5.1.3 Cosmetics and Personal Care
  5. 5.1.4 Others
  6. 5.2 Global Cytotoxicity Testing Services Sales Value by Application
  7. 5.2.1 Global Cytotoxicity Testing Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cytotoxicity Testing Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global Cytotoxicity Testing Services Sales Value Share by Application (2021-2032)
6 Cytotoxicity Testing Services Regional Value Analysis
  1. 6.1 Global Cytotoxicity Testing Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cytotoxicity Testing Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cytotoxicity Testing Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cytotoxicity Testing Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cytotoxicity Testing Services Sales Value (2021-2032)
  7. 6.3.2 North America Cytotoxicity Testing Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cytotoxicity Testing Services Sales Value (2021-2032)
  10. 6.4.2 Europe Cytotoxicity Testing Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cytotoxicity Testing Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cytotoxicity Testing Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cytotoxicity Testing Services Sales Value (2021-2032)
  16. 6.6.2 South America Cytotoxicity Testing Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cytotoxicity Testing Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cytotoxicity Testing Services Sales Value Share by Country, 2025 VS 2032
7 Cytotoxicity Testing Services Country-level Value Analysis
  1. 7.1 Global Cytotoxicity Testing Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cytotoxicity Testing Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cytotoxicity Testing Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cytotoxicity Testing Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cytotoxicity Testing Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cytotoxicity Testing Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cytotoxicity Testing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sartorius
  2. 8.1.1 Sartorius Company Information
  3. 8.1.2 Sartorius Business Overview
  4. 8.1.3 Sartorius Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sartorius Cytotoxicity Testing Services Product Portfolio
  6. 8.1.5 Sartorius Recent Developments
  7. 8.2 Eurofins Scientific
  8. 8.2.1 Eurofins Scientific Company Information
  9. 8.2.2 Eurofins Scientific Business Overview
  10. 8.2.3 Eurofins Scientific Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eurofins Scientific Cytotoxicity Testing Services Product Portfolio
  12. 8.2.5 Eurofins Scientific Recent Developments
  13. 8.3 TÜV SÜD
  14. 8.3.1 TÜV SÜD Company Information
  15. 8.3.2 TÜV SÜD Business Overview
  16. 8.3.3 TÜV SÜD Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TÜV SÜD Cytotoxicity Testing Services Product Portfolio
  18. 8.3.5 TÜV SÜD Recent Developments
  19. 8.4 Nelson Labs
  20. 8.4.1 Nelson Labs Company Information
  21. 8.4.2 Nelson Labs Business Overview
  22. 8.4.3 Nelson Labs Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nelson Labs Cytotoxicity Testing Services Product Portfolio
  24. 8.4.5 Nelson Labs Recent Developments
  25. 8.5 Pacific BioLabs
  26. 8.5.1 Pacific BioLabs Company Information
  27. 8.5.2 Pacific BioLabs Business Overview
  28. 8.5.3 Pacific BioLabs Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pacific BioLabs Cytotoxicity Testing Services Product Portfolio
  30. 8.5.5 Pacific BioLabs Recent Developments
  31. 8.6 Emery Pharma
  32. 8.6.1 Emery Pharma Company Information
  33. 8.6.2 Emery Pharma Business Overview
  34. 8.6.3 Emery Pharma Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Emery Pharma Cytotoxicity Testing Services Product Portfolio
  36. 8.6.5 Emery Pharma Recent Developments
  37. 8.7 UFAG Laboratorien AG
  38. 8.7.1 UFAG Laboratorien AG Company Information
  39. 8.7.2 UFAG Laboratorien AG Business Overview
  40. 8.7.3 UFAG Laboratorien AG Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 UFAG Laboratorien AG Cytotoxicity Testing Services Product Portfolio
  42. 8.7.5 UFAG Laboratorien AG Recent Developments
  43. 8.8 NorthEast BioLab
  44. 8.8.1 NorthEast BioLab Company Information
  45. 8.8.2 NorthEast BioLab Business Overview
  46. 8.8.3 NorthEast BioLab Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 NorthEast BioLab Cytotoxicity Testing Services Product Portfolio
  48. 8.8.5 NorthEast BioLab Recent Developments
  49. 8.9 Biosafe Ltd
  50. 8.9.1 Biosafe Ltd Company Information
  51. 8.9.2 Biosafe Ltd Business Overview
  52. 8.9.3 Biosafe Ltd Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Biosafe Ltd Cytotoxicity Testing Services Product Portfolio
  54. 8.9.5 Biosafe Ltd Recent Developments
  55. 8.10 Creative Bioarray
  56. 8.10.1 Creative Bioarray Company Information
  57. 8.10.2 Creative Bioarray Business Overview
  58. 8.10.3 Creative Bioarray Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Creative Bioarray Cytotoxicity Testing Services Product Portfolio
  60. 8.10.5 Creative Bioarray Recent Developments
  61. 8.11 Evercyte
  62. 8.11.1 Evercyte Company Information
  63. 8.11.2 Evercyte Business Overview
  64. 8.11.3 Evercyte Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Evercyte Cytotoxicity Testing Services Product Portfolio
  66. 8.11.5 Evercyte Recent Developments
  67. 8.12 IONTOX
  68. 8.12.1 IONTOX Company Information
  69. 8.12.2 IONTOX Business Overview
  70. 8.12.3 IONTOX Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 IONTOX Cytotoxicity Testing Services Product Portfolio
  72. 8.12.5 IONTOX Recent Developments
  73. 8.13 Applied StemCell
  74. 8.13.1 Applied StemCell Company Information
  75. 8.13.2 Applied StemCell Business Overview
  76. 8.13.3 Applied StemCell Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Applied StemCell Cytotoxicity Testing Services Product Portfolio
  78. 8.13.5 Applied StemCell Recent Developments
  79. 8.14 Xenometrix AG
  80. 8.14.1 Xenometrix AG Company Information
  81. 8.14.2 Xenometrix AG Business Overview
  82. 8.14.3 Xenometrix AG Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Xenometrix AG Cytotoxicity Testing Services Product Portfolio
  84. 8.14.5 Xenometrix AG Recent Developments
  85. 8.15 Medicilon
  86. 8.15.1 Medicilon Company Information
  87. 8.15.2 Medicilon Business Overview
  88. 8.15.3 Medicilon Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Medicilon Cytotoxicity Testing Services Product Portfolio
  90. 8.15.5 Medicilon Recent Developments
  91. 8.16 UL
  92. 8.16.1 UL Company Information
  93. 8.16.2 UL Business Overview
  94. 8.16.3 UL Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 UL Cytotoxicity Testing Services Product Portfolio
  96. 8.16.5 UL Recent Developments
  97. 8.17 SGS
  98. 8.17.1 SGS Company Information
  99. 8.17.2 SGS Business Overview
  100. 8.17.3 SGS Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 SGS Cytotoxicity Testing Services Product Portfolio
  102. 8.17.5 SGS Recent Developments
  103. 8.18 iuvo BioScience
  104. 8.18.1 iuvo BioScience Company Information
  105. 8.18.2 iuvo BioScience Business Overview
  106. 8.18.3 iuvo BioScience Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 iuvo BioScience Cytotoxicity Testing Services Product Portfolio
  108. 8.18.5 iuvo BioScience Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst